SH2D1A and tuberculosis: By linking DEGs against immune cell populations and TB gene signature, this study identified 9 CD8+ T cells associated genes (ITK, CD2, CD6, CD247, ZAP70, CD3D, SH2D1A, CD3E, and IL7R) as potential therapeutic targets of PTB.